Cite
Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients.
MLA
Politis, Marios, et al. “Sustained Striatal Dopamine Levels Following Intestinal Levodopa Infusions in Parkinson’s Disease Patients.” Movement Disorders, vol. 32, no. 2, Feb. 2017, pp. 235–40. EBSCOhost, https://doi.org/10.1002/mds.26848.
APA
Politis, M., Sauerbier, A., Loane, C., Pavese, N., Martin, A., Corcoran, B., Brooks, D. J., Ray, C. K., Piccini, P., & Ray-Chaudhuri, K. (2017). Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson’s disease patients. Movement Disorders, 32(2), 235–240. https://doi.org/10.1002/mds.26848
Chicago
Politis, Marios, Anna Sauerbier, Clare Loane, Nicola Pavese, Anne Martin, Benjamin Corcoran, David J. Brooks, Chaudhuri, K. Ray, Paola Piccini, and K Ray-Chaudhuri. 2017. “Sustained Striatal Dopamine Levels Following Intestinal Levodopa Infusions in Parkinson’s Disease Patients.” Movement Disorders 32 (2): 235–40. doi:10.1002/mds.26848.